Potentiation of imipramine-induced antinociception by nicotine in the formalin test

European Neuropsychopharmacology

Volumn 14, Issue 1, 2004, Pages 71-76

  Zarrindast, Mohammad Reza ^a   Baghdadi, Banafsheh ^a   Sahebgharani, Mousa ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antinociception; Imipramine; Nicotinic mechanism

Indexed keywords

ANALGESIC AGENT; ATROPINE; FORMALDEHYDE; HEXAMETHONIUM; IMIPRAMINE; MECAMYLAMINE; NICOTINE; NICOTINIC RECEPTOR;

ANIMAL; ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG COMBINATION; DRUG EFFECT; DRUG POTENTIATION; MALE; METHODOLOGY; MOUSE; NONHUMAN; PAIN ASSESSMENT; PRIORITY JOURNAL;

EID: 0345118040     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-977X(03)00066-X     Document Type: Article

References (50)

1. Abbott F.V., Franklin K.B., Ludwik R.J., Melzack R. Apparent lack of tolerance in the formalin test suggests different mechanisms for morphine analgesia in different types of pain. Pharmacol. Biochem. Behav. 15:1981;637-640.
2. Aceto M.D., Bagley R.S., Dewey W.L., Fu T.C., Martin B.R. The spinal cord as a major site for the antinociceptive action of nicotine in the rat. Neuropharmacology. 25:1986;1031-1036.
3. Caggiula A.R., Epstein L.H., Perkins K.A., Saylor S. Different methods of assessing nicotine-induced antinociception may engage different neural mechanisms. Psychopharmacology. 122:1995;301-306.
4. Clavelou P., Radhouane D., Thierry O., Alain W., Patrich R. The orofacial formalin test in rat, effect of different formalin concentrations. Pain. 62:1995;295-301.
5. Cordero-Erausquin M., Changeux J.P. Tonic nicotinic modulation of serotoninergic transmission in the spinal cord. Proc. Natl. Acad. Sci. USA. 98:2001;2803-2807.
6. Damaj M.I., Welch S.P., Martin B.R. Characterization and modulation of acute tolerance to nicotine in mice. J. Pharmacol. Exp. Ther. 277:1996;454-461.
7. Davenport K.E., Houdi A.A., Van Loon G.R. Nicotine protects against μ-opioid receptor antagonism by β-funaltrexamine: evidence for nicotine-induced release of endogenous opioids in brain. Neurosci. Lett. 113:1990;40-46.
8. Dubuisson D., Dennis S.G. The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain. 4:1977;161-174.
9. Eisenach J.C., Gehart G.F. Intrathecal amitriptyline, antinociceptive interaction with intravenous morphine and intrathecal clonidine, neostigmine and carbamylcholine in rats. Anesthesiology. 83:1995;1036-1045.
10. Feinmann C. Pain relief by antidepressants; possible modes of action. Pain. 23:1985;1-8.
11. 3H]dopamine release from synaptosomes prepared from four mouse brain regions. J. Pharmacol. Exp. Ther. 301:2002;651-660.
12. Gray A.M., Spencer P.S., Sewell R.D. The involvement of the opioidergic system in the antinociceptive mechanism of action of antidepressant compounds. Br. J. Pharmacol. 124:1998;669-674.
13. Hunskaar S., Fasmer O.B., Hole K. Formalin test in mice, a useful technique for evaluating mild analgesic. J. Neurosci. Meth. 14:1985;69-76.
14. Hunskaar S., Hole K. The formalin test in mice: dissociation between inflammatory and noninflammatory pain. Pain. 30:1987;103-114.
15. Iwashita T., Shimizu T. Imipramine inhibits intrathecal substance P-induced behavior and blocks spinal cord substance P receptors in mice. Brain Res. 581:1992;59-66.
16. Jett M.F., McGurick J., Waligora D., Hunter J.C. The effect of mexiletine, desipramine and fluoxetine in rat models involving central sensitization. Pain. 69:1997;161-169.
17. Jett M.F., Michelson S. The formalin test in rat: validation of an automated system. Pain. 64:1996;19-25.
18. Lang E., Hord A.H., Denson D. Venlafaxine hydrochloride (Effexor™) relieves thermal hyperalgesia in rats with an experimental mononeuropathy. Pain. 68:1996;151-155.
19. Leonard B.E., Richelson E. Synaptic effects of antidepressants. Buckley P.F., Waddington J.L. Schizophrenia and Mood Disorders: The New Drug Therapies in Clinical Practice. 2000;67-84 Butterworth-Heinemann, Boston.
20. Li X., Eisenach J.C. Nicotinic acetylcholine receptor regulation of spinal norepinephrine release. Anesthesiology. 96:2002;1450-1456.
21. Lopez E., Arce C., Vicente S., Oset-Gasque M.J., Gonzalez M.P. Nicotinic receptors mediate the release of amino acid neurotransmitters in cultured cortical neurons. Cereb. Cortex. 11:2001;158-163.
22. 3H]γ-aminobutyric acid release from mouse brain synaptosomes is produced by subactivating concentrations of agonists. J. Pharmacol. Exp. Ther. 291:1999;1127-1134.
23. MacDermott A.B., Role L.W., Siegelbaum S.A. Presynaptic iontropic receptors and the control of transmitters release. Annu. Rev. Neurosci. 22:1999;443-485.
24. Magni G. The use of antidepressants in the treatment of chronic pain. A review of current evidence. Drugs. 42:1991;730-748.
25. Max M.B. Antidepressant drugs as treatment for chronic pain: efficacy and mechanisms. Adv. Pain Res. Ther. 22:1995;501-515.
26. Max M.B., Lynch S.A., Muir J. Effects of desipramine, amitriptyline and fluoxetine on pain in diabetic neuropathy. New Engl. J. Med. 326:1992;1250-1256.
27. Max M.B., Schafer S.C., Culnance M., Dubner R., Gracely R.H. Association of pain relief with drug side effects in postherptic neuralgia: a single-dose study of clonidine, codeine, ibuprofen and placebo. Clin. Pharmacol. Ther. 43:1988;363-371.
28. Onghena P., Houdenhove B.V. Antidepressant induced analgesia in chronic nonmalignant pain: a meta-analysis of placebo-controlled studies. Pain. 49:1992;205-219.
29. Phan D.V., Doda M., Bile A., Gyorgy L. Antinociceptive activity of nicotine. Acta Physiol. Acad. Sci. Hung. 1:1973;85-93.
30. Rana B., McMorn S.O., Reeve H.L., Wyatt C.N., Vaughan P.F.T., Peers C. Inhibition of neural nicotinic acetylcholine receptors by imipramine and desipramine. Eur. J. Pharmacol. 250:1993;247-251.
31. Rau H., Schweizer R., Zhuang P., Brody S., Larbig W., Heinle H., Muller M., Elbert T., Dworkin B., Birbaumer N. Cigarette smoking, blood lipids, and baroreceptor-modulated nociception. Psychopharmacology. 110:1993;337-341.
32. Richeimer S.H., Bajwa Z.H., Kahrama S.S., Ransil B.J., Warfield C.A. Utilization patterns of tricyclic antidepressants in a multidisciplinary pain clinic: a survey. Clin. J. Pain. 13:1997;324-329.
33. Rosenblatt M.R., Reich J., Dehring D. Tricyclic antidepressants in treatment of depression and chronic pain. Anesth. Analg. 63:1984;1025-1032.
34. Sabetkasai M., Ahang S., Shafaghi B., Zarrindast M.R. Baclofen-induced antinociception and nicotine receptor mechanism(s). Pharmacol. Toxicol. 85:1999;247-251.
35. Sacerdote P., Brini A., Mantegazza P., Panerai A.E. A role for serotonin and β-endorphin in the analgesia induced by some tricyclic antidepressant drugs. Pharmacol. Biochem. Behav. 26:1987;153-158.
36. Shibata M., Ohkubo T., Takahashi H., Inoki R. Modified formalin test: characteristic biphasic pain response. Pain. 38:1989;347-352.
37. Sierralta F., Pinardi G., Miranda H.F. Effect of P-chlorophenylalanine and α-methyltyrosine on the antinociceptive effect of antidepressant drugs. Pharmacol. Toxicol. 77:1995;276-280.
38. Sindrup S.H., Jensen T.S. Efficacy of pharmacological treatments of neuropathic pain: an update effect related to mechanism of drug action. Pain. 83:1999;389-400.
39. Snyder S.H., Yamamura H.I. Antidepressants and the acetylcholine receptor. Arch. Gen. Psychiat. 34:1977;236-241.
40. Tanelian D.L., Brose W.G. Neuropathic pain can be relieved by drugs that are use-dependant sodium channel blockers: lidocaine, carbamozepine and mexiletine. Anaesthesiology. 74:1991;949-951.
41. Valverde O., Mico J.A., Maldonado R., Mellado M., Gibertrahola J. Participation of opioid and monoaminergic mechanisms on the antinociceptive effect induced by tricyclic antidepressants in two behavioral pain tests in mice. Prog. Neuropsychopharmacol. Biol. Psychiatry. 18:1994;1073-1092.
42. Ventafridda V., Bianchi M., Ripamonti C., Sacerdote P., De Conno F., Zecca E., Panerai A.E. Studies on the effects of antidepressant drugs on the antinociceptive action of morphine and on plasma morphine in rat and man. Pain. 43:1990;155-162.
43. Yang Y.C., Kuo C.C. Inhibition of Na(+) current by imipramine and related compounds: different binding kinetics as an inactivation stabilizer and as an open channel blocker. Mol. Pharmacol. 62:2002;1228-1237.
44. Yokogawa F., Kiuchi Y., Ishikawa Y., Otsuka N., Masuda Y., Oguchi K., Hosoyamada A. An investigation of monoamine receptors involved in antinociceptive effects of antidepressants. Anesth. Analg. 95:2002;163-168.
45. Zarrindast M.R., Farzin D. Nicotine attenuates naloxone-induced jumping behaviour in morphine-dependent mice. Eur. J. Pharmacol. 298:1996;1-6.
46. Zarrindast M.R., Nami A.B., Farzin D. Nicotine potentiates morphine antinociception: a possible cholinergic mechanism. Eur. Neuropsychopharnmacol. 6:1996;127-133.
47. Zarrindast M.R., Shaverdian Sh., Sahebgharani M. Effect of imipramine on tolerance to morphine antinociception in the formalin test. Pharmacol. Toxicol. 87:2000;131-137.
48. Zarrindast M., Valizadeh S., Sahebgharani M. GABA(B) receptor mechanism and imipramine-induced antinociception in ligated and nonligated mice. Eur. J. Pharmacol. 407:2000;65-72.
49. Zarrindast M.R., Zabihi A., Rezayat M., Rakhshandeh H., Ghazi-Khansari M., Hosseini R. Effects of Caerulein and CCK antagonists on tolerance induced to morphine antinociception in mice. Pharmacol. Biochem. Behav. 58:1997;173-178.
50. Zarrindast M.R., Zarghi A., Amiri A. Nicotine-induced hypothermia through an indirect dopaminergic mechanism. J. Psychopharmacol. 9:1995;20-24.